title: T cell/histiocyte-rich large B-cell lymphoma: an update on its biology and classification.
abstract: T cell/histiocyte-rich large B-cell lymphoma (THRLBCL), originally considered an uncommon variant of Diffuse Large B-Cell Lymphoma (DLBCL), is recognized by the World Health Organisation as a separate clinicopathological entity since 2008. It predominantly affects middle aged men often presenting with advanced stage disease frequently involving spleen, liver and bone marrow at time of diagnosis. According to the WHO, this lymphoma is morphologically characterized by less than 10% of large neoplastic B cells in a background of abundant T cells and frequently histiocytes. Differentiating THRLBCL from other lymphoproliferative disorders such as Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Lymphocyte-Rich classical Hodgkin lymphoma (LRcHL) is important from a clinical point of view and can be achieved in most cases, given adequate biopsy specimens, by careful morphological and immunohistochemical evaluation of both the neoplastic cells as well as the nonneoplastic stromal component. According to this WHO definition, THRLBCL is still considered a clinically heterogeneous entity, though it is noted that especially the cases containing numerous histiocytes behave aggressively and show resistance to current therapies for DLBCL. Gene expression profiling studies of THRLBCL provided evidence for a prominent role for this histiocytic component that is important for a tolerogenic host immune response in which they may assist neoplastic cells in escaping the T cell-mediated immune surveillance. Therefore, reserving the diagnosis of THRLBCL to cases containing a large proportion of histiocytes might be relevant, as modulating their activity could provide new therapeutic options.
authors.affiliation: Morphology and Molecular Pathology Section, University Hospitals KU, Leuven, Leuven, Belgium, thomas.tousseyn@uzleuven.be
authors.forename: Thomas
authors.initials: T
authors.lastname: Tousseyn
authors.forename: Christiane
authors.initials: C
authors.lastname: De Wolf-Peeters
mesh_terms: D003937:Diagnosis, Differential; D020869:Gene Expression Profiling; D006644:Histiocytes / Q000473:pathology*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000145:classification* / Q000175:diagnosis / Q000473:pathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000145:classification / Q000175:diagnosis / Q000473:pathology; D013601:T-Lymphocytes / Q000473:pathology*; D014944:World Health Organization
references.citation: Blood. 1999 Apr 15;93(8):2679-87
references.pmid: 10194448
references.citation: Am J Surg Pathol. 2002 Nov;26(11):1458-66
references.pmid: 12409722
references.citation: Cancer. 2000 May 15;88(10):2378-86
references.pmid: 10820362
references.citation: Oncologist. 2006 Apr;11(4):384-92
references.pmid: 16614234
references.citation: J Clin Oncol. 2003 Apr 1;21(7):1271-7
references.pmid: 12663714
references.citation: Blood. 1997 Jul 1;90(1):244-51
references.pmid: 9207459
references.citation: Leuk Lymphoma. 2005 Sep;46(9):1295-300
references.pmid: 16109606
references.citation: Nat Rev Cancer. 2009 Jun;9(6):445-52
references.pmid: 19461669
references.citation: Histopathology. 2002 Sep;41(3):216-29
references.pmid: 12207783
references.citation: Histopathology. 2002 Jan;40(1):31-45
references.pmid: 11903596
references.citation: J Clin Oncol. 1995 Jul;13(7):1742-50
references.pmid: 7602364
references.citation: Semin Hematol. 1999 Jul;36(3):220-32
references.pmid: 10462322
references.citation: J Clin Oncol. 1999 Mar;17(3):776-83
references.pmid: 10071266
references.citation: Am J Surg Pathol. 1988 Jun;12(6):433-43
references.pmid: 3287959
references.citation: J Clin Oncol. 2002 Mar 1;20(5):1269-77
references.pmid: 11870169
references.citation: Blood. 2009 Mar 19;113(12):2765-3775
references.pmid: 19096012
references.citation: Blood. 2003 Nov 15;102(10):3753-8
references.pmid: 12881319
references.citation: N Engl J Med. 2004 Nov 18;351(21):2159-69
references.pmid: 15548776
references.citation: Histopathology. 1995 Apr;26(4):383-5
references.pmid: 7541773
references.citation: Blood. 2005 Mar 1;105(5):1851-61
references.pmid: 15550490
references.citation: Leuk Res. 2004 Mar;28(3):229-36
references.pmid: 14687617
references.citation: Blood. 1993 Sep 1;82(5):1586-9
references.pmid: 8364208
references.citation: Haematologica. 2010 Mar;95(3):440-8
references.pmid: 19797726
references.citation: N Engl J Med. 2008 Nov 27;359(22):2313-23
references.pmid: 19038878
references.citation: Ann Hematol. 2011 Apr;90(4):409-16
references.pmid: 20938662
references.citation: Am J Pathol. 2001 Nov;159(5):1807-14
references.pmid: 11696441
references.citation: Cancer. 1985 Oct 1;56(7):1578-83
references.pmid: 3875393
references.citation: Leuk Lymphoma. 2007 Sep;48(9):1764-73
references.pmid: 17786712
references.citation: Blood. 2001 Mar 15;97(6):1845-53
references.pmid: 11238128
references.citation: N Engl J Med. 1997 Aug 14;337(7):453-8
references.pmid: 9250847
references.citation: Am J Surg Pathol. 1994 May;18(5):455-65
references.pmid: 8172320
references.citation: Am J Surg Pathol. 1992 Jan;16(1):37-48
references.pmid: 1728195
references.citation: Am J Surg Pathol. 2003 Oct;27(10):1346-56
references.pmid: 14508396
references.citation: J Exp Med. 2008 Sep 29;205(10):2251-68
references.pmid: 18794340
references.citation: Hum Pathol. 1989 Dec;20(12):1169-75
references.pmid: 2591946
references.citation: Am J Surg Pathol. 1990 Oct;14(10):933-8
references.pmid: 2169708
references.citation: Blood. 2009 Mar 12;113(11):2394-401
references.pmid: 19023117
references.citation: Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9337-42
references.pmid: 9256483
references.citation: Histopathology. 1991 Sep;19(3):211-20
references.pmid: 1655614
references.citation: Cancer Res. 1988 Jan 1;48(1):37-40
references.pmid: 3275493
references.citation: APMIS. 2002 May;110(5):379-90
references.pmid: 12076255
references.citation: Am J Surg Pathol. 2003 Jul;27(7):903-11
references.pmid: 12826882